[Heterotopic heart transplantation: 13-year experience at the Methodist Hospital of the Baylor Medical College].

E Herrera Garza, G P Noon, J B Durand, S J Stetson, S Zylicz, L Johnson, R Cano Niño, F Herrera Flores, G Torre-Amione
{"title":"[Heterotopic heart transplantation: 13-year experience at the Methodist Hospital of the Baylor Medical College].","authors":"E Herrera Garza,&nbsp;G P Noon,&nbsp;J B Durand,&nbsp;S J Stetson,&nbsp;S Zylicz,&nbsp;L Johnson,&nbsp;R Cano Niño,&nbsp;F Herrera Flores,&nbsp;G Torre-Amione","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Unlabelled: </strong>In order to evaluate our experience in heterotopic cardiac transplantation, we conducted a retrospective analysis of the clinical files of patients who underwent this procedure.</p><p><strong>Results: </strong>A total of 405 heart transplants were performed in our institution. In 24 (5.9%), the grafts were placed heterotopically. In group I (12 patients), the indication was irreversible pulmonary hypertension and in group II (remaining 12 patients), it was marginal grafts or size mismatch. Both groups demonstrated similar demographics and the survival rate was slightly better in group I. Nine patients from group I demonstrated an early reduction in pulmonary pressures which normalized in one year.</p><p><strong>Conclusions: </strong>The heterotopic heart supports the function of the native ventricles. In 9 patients, the heterotopic heart enables the reversal of a state of pulmonary hypertension previously thought to be irreversible. This finding supports the use of pulmonary vaso-dilators on a chronic basis or the use of a left ventricular assist device pre-transplant with the intention of normalizing pulmonary pressures and allowing the patients to become candidates for orthotopic cardiac transplantation and thereby avoiding the necessity of heterotopic cardiac transplantation.</p>","PeriodicalId":75556,"journal":{"name":"Archivos del Instituto de Cardiologia de Mexico","volume":"69 6","pages":"526-33"},"PeriodicalIF":0.0000,"publicationDate":"1999-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos del Instituto de Cardiologia de Mexico","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Unlabelled: In order to evaluate our experience in heterotopic cardiac transplantation, we conducted a retrospective analysis of the clinical files of patients who underwent this procedure.

Results: A total of 405 heart transplants were performed in our institution. In 24 (5.9%), the grafts were placed heterotopically. In group I (12 patients), the indication was irreversible pulmonary hypertension and in group II (remaining 12 patients), it was marginal grafts or size mismatch. Both groups demonstrated similar demographics and the survival rate was slightly better in group I. Nine patients from group I demonstrated an early reduction in pulmonary pressures which normalized in one year.

Conclusions: The heterotopic heart supports the function of the native ventricles. In 9 patients, the heterotopic heart enables the reversal of a state of pulmonary hypertension previously thought to be irreversible. This finding supports the use of pulmonary vaso-dilators on a chronic basis or the use of a left ventricular assist device pre-transplant with the intention of normalizing pulmonary pressures and allowing the patients to become candidates for orthotopic cardiac transplantation and thereby avoiding the necessity of heterotopic cardiac transplantation.

[异位心脏移植:贝勒医学院卫理公会医院13年的经验]。
未标记:为了评价我们在异位心脏移植方面的经验,我们对接受该手术的患者的临床档案进行了回顾性分析。结果:我院共完成心脏移植手术405例。24例(5.9%)为异位移植物。I组(12例)的适应症为不可逆肺动脉高压,II组(剩余12例)的适应症为边缘移植物或大小不匹配。两组表现出相似的人口统计学特征,I组的生存率稍好一些。I组的9名患者表现出早期肺压降低,并在一年内正常化。结论:异位心脏支持天然心室功能。在9例患者中,异位心脏使先前认为不可逆转的肺动脉高压状态得以逆转。这一发现支持在慢性基础上使用肺血管扩张剂或在移植前使用左心室辅助装置,目的是使肺压力正常化,使患者成为原位心脏移植的候选者,从而避免异位心脏移植的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信